ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 221 filers reported holding ALKERMES PLC in Q3 2021. The put-call ratio across all filers is 2.83 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $921,557 | -14.1% | 32,901 | -4.0% | 0.01% | -14.3% |
| Q2 2023 | $1,072,588 | +10.3% | 34,268 | -0.6% | 0.01% | +16.7% |
| Q1 2023 | $972,301 | -8.2% | 34,491 | -14.9% | 0.01% | 0.0% |
| Q4 2022 | $1,059,232 | +68.1% | 40,537 | +43.6% | 0.01% | +100.0% |
| Q3 2022 | $630,000 | -28.7% | 28,226 | -4.8% | 0.00% | -25.0% |
| Q2 2022 | $883,000 | +21.6% | 29,653 | +7.4% | 0.00% | +33.3% |
| Q1 2022 | $726,000 | +61.3% | 27,612 | +42.8% | 0.00% | 0.0% |
| Q4 2021 | $450,000 | -13.6% | 19,332 | +14.5% | 0.00% | 0.0% |
| Q3 2021 | $521,000 | +30.2% | 16,883 | +3.6% | 0.00% | 0.0% |
| Q2 2021 | $400,000 | – | 16,294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 8,964,640 | $234,246,043 | 27.88% |
| Krensavage Asset Management, LLC | 1,401,783 | $36,629 | 11.32% |
| Hardman Johnston Global Advisors LLC | 5,561,806 | $145,329,991 | 5.69% |
| 13D Management LLC | 383,584 | $10,023,050 | 5.27% |
| Prosight Management, LP | 341,521 | $8,923,944 | 4.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $15,483,230 | 4.78% |
| Tamarack Advisers, LP | 275,000 | $7,185,750 | 3.70% |
| Ally Bridge Group (NY) LLC | 142,002 | $3,710,512 | 3.61% |
| HealthCor Management, L.P. | 110,000 | $2,874,300 | 2.63% |
| Price Jennifer C. | 360,600 | $9,422,478 | 2.25% |